发明名称 NOVEL HETEROCYCLIDENE ACETAMIDE DERIVATIVE
摘要 <p>A compound represented by formula (I'): (wherein m, n, and p each represent 0 to 2; q represents 0 or 1; R 1 represents halogen, a hydrocarbon group, a heterocyclic group, an alkoxy group, an alkoxycarbonyl group, a sulfamoyl group, a CN group, an NO 2 group, or the like; R 2 represents halogen, amino, a hydrocarbon group, an aromatic heterocyclic group, or an oxo group; X 1 represents O, -NR 3 -, or -S(O)r-; X 2 represents a methylene group, O, -NR 3 -, or - S(O)r-; Q' represents a heteroaryl group, a heteroarylalkyl group, a substituted aryl group, or an aralkyl group; Cycle moiety represents an aryl ring or a heteroaryl ring; and the wavy line represents an E-isomer or a Z-isomer), a salt of the compound, or a solvate of the compound or the salt. A pharmaceutical composition and a transient receptor potential type I (TRPV1) receptor antagonist each contain, as an active ingredient, at least one of the compound, a salt of the compound, and a solvate of the compound or the salt.</p>
申请公布号 PT1908753(E) 申请公布日期 2015.02.06
申请号 PT20060779892T 申请日期 2006.07.24
申请人 MOCHIDA PHARMACEUTICAL CO., LTD. 发明人 HIDEHARU UCHIDA;NAOTO KOSUGA;TSUTOMU SATOH;DAIDO HOTTA;TOMOYUKI KAMINO;YOSHITAKA MAEDA;KEN-ICHI AMANO;YASUSHIGE AKADA
分类号 C07D215/38;A61K31/4155;A61K31/416;A61K31/427;A61K31/428;A61K31/433;A61K31/435;A61K31/437;A61K31/4709;A61K31/4725;A61K31/498;A61K31/5377;A61K31/538;A61P1/04;A61P3/04;A61P9/00;A61P9/10;A61P11/00;A61P11/06;A61P13/12 主分类号 C07D215/38
代理机构 代理人
主权项
地址